1-2 of 2
Hayley Ma
Close
Sort by
Journal Articles

TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo

Hayley Ma, Bao Nguyen, Li Li, Sarah Greenblatt, Allen Williams, Ming Zhao, Mark Levis, Michelle Rudek, Amy Duffield, Donald Small
Journal: Blood
Blood (2014) 123 (10): 1525–1534.
https://doi.org/10.1182/blood-2013-08-523035
Published: 2014
Includes: Supplemental data
Journal Articles

Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants

Allison Galanis, Hayley Ma, Trivikram Rajkhowa, Abhijit Ramachandran, Donald Small, Jorge Cortes, Mark Levis
Journal: Blood
Blood (2014) 123 (1): 94–100.
https://doi.org/10.1182/blood-2013-10-529313
Published: 2014
Includes: Supplemental data